Actively Recruiting
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
Led by University Hospital, Lille · Updated on 2024-06-24
320
Participants Needed
1
Research Sites
388 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Lille
Lead Sponsor
S
Santelys Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
Thoracic aneurysm is a silent disease with a potential mid-term high risk of death or major complications. Few data are available on the real incidence of major complications in case of small and moderate thoracic aneurysm. Different factors are supposed to increase the risk of aortic enlargement as high blood pressure and sleep disorder breathing. The modality of imaging and clinical follow-up are well defined. In this prospective observational study, the aim to assess the incidence of of major complications during follow-up in a population of patients with a small or moderate thoracic aneurysm. The study will also try to identify systemic factors influencing aneurysm evolution.
CONDITIONS
Official Title
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented aortic root aneurysm larger than 40 mm
- Willingness to participate in a long-term study with a 5-year follow-up
You will not qualify if you...
- Having other illnesses or conditions expected to limit life to less than 1 year
- Personal or family history of genetically confirmed elastic tissue diseases or meeting clinical criteria for Marfan disease
- Severe mitral or aortic valve disease, even without symptoms
- Uncontrolled high blood pressure with readings equal to or above 180/110 mmHg
- Aneurysms equal to or larger than 50 mm in any thoracic or abdominal location
- Aneurysms that have grown more than 5 mm in one year
- Previous aortic surgery, endovascular procedures, or type B aortic dissection treated medically
- Kidney failure requiring dialysis or severe kidney impairment with GFR less than 30 ml/min (CKD-EPI)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Lille
Lille, Please Choose..., France, 59037
Actively Recruiting
Research Team
P
Pascal DELSART, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here